Title : Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

Pub. Date : 2016 Nov

PMID : 27572942






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The oral synthetic oligonucleotide toll-like receptor-9 modulator has demonstrated anti-inflammatory properties in colitis murine models and a satisfactory safety profile in humans. Oligonucleotides toll like receptor 9 Homo sapiens